Health Care & Life Sciences » Pharmaceuticals | BioDelivery Sciences International Inc.

BioDelivery Sciences International Inc.

BioDelivery Sciences International Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
59.35 M
Public Float
51.87 M
BioDelivery Sciences International Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.6
Market Cap
$413.56 M
Shares Outstanding
89.43 M
Public Float
65.12 M

Profile

Address
4131 ParkLake Avenue
Raleigh North Carolina 27612
United States
Employees -
Website http://www.bdsi.com
Updated 07/08/2019
BioDelivery Sciences International, Inc. is a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

Financials

View All

Herm Cukier
Chief Executive Officer & Director
Kevin Kotler
Director